PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Paliperidone (Injection)
Presentation Product Chemical substance Chapter Items dispensed
Paliperidone 150mg/1.5ml prolonged-release inj pf syringes
0402020ABAAADAD
Paliperidone (Injection) Paliperidone Central Nervous System 1,511
Paliperidone 100mg/1ml prolonged-release inj pf syringes
0402020ABAAACAC
Paliperidone (Injection) Paliperidone Central Nervous System 1,299
Paliperidone 75mg/0.75ml prolonged-release inj pf syringes
0402020ABAAABAB
Paliperidone (Injection) Paliperidone Central Nervous System 754
Paliperidone 50mg/0.5ml prolonged-release inj pf syringes
0402020ABAAAAAA
Paliperidone (Injection) Paliperidone Central Nervous System 433
Paliperidone 525mg/2.625ml prolonged-release inj pf syringes
0402020ABAAAIAI
Paliperidone (Injection) Paliperidone Central Nervous System 77
Paliperidone 350mg/1.75ml prolonged-release inj pf syringes
0402020ABAAAHAH
Paliperidone (Injection) Paliperidone Central Nervous System 65
Paliperidone 263mg/1.315ml prolonged-release inj pf syringes
0402020ABAAAGAG
Paliperidone (Injection) Paliperidone Central Nervous System 47
Paliperidone 175mg/0.875ml prolonged-release inj pf syringes
0402020ABAAAFAF
Paliperidone (Injection) Paliperidone Central Nervous System 31
Paliperidone 700mg/3.5ml prolonged-release inj pf syringes
0402020ABAAAKAK
Paliperidone (Injection) Paliperidone Central Nervous System 2
Paliperidone 1g/5ml prolonged-release inj pf syringes
0402020ABAAAJAJ
Paliperidone (Injection) Paliperidone Central Nervous System 1
Paliperidone 150mg/1.5ml inj and Paliperidone 100mg/1ml inj
0402020ABAAAEAE
Paliperidone (Injection) Paliperidone Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.